Evaluation of Non-Invasive Assays for the Detection of Urothelial Cancer

Recruiting now

Conditions studied: Urothelial Cancer, Cancer, Bladder Neoplasms, Urinary Bladder Cancer

In brief

The purpose of this study is to determine if analysis of DNA and protein material found in urine will be useful in the detection of urothelial cancer of the bladder and kidney. This analysis may be helpful to determine if how a particular cancer will act regarding remission and recurrence

Key facts

Study ID

NCT00872495

Run by

Lahey Clinic

People needed

500

Starts

2002-09-01

Expected to finish

2028-11-01

Last updated by the study team

2025-12-08

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Patients scheduled to have a nephroureterectomy, cystectomy, cytoscopy (newly diagnosed bladder cancer and those with recurrent disease in follow up)
• Control Group: No known evidence of bladder cancer-one urine sample
• > than 18 years of age

You may not qualify if…

• < than 18 years of age

Where it is running

• Lahey Clinic, Inc. — Burlington, Massachusetts, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.